Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal(Michael E. DeBakey VA Medical Center), Hashem B. El‐Serag(Baylor College of Medicine), Maneerat Chayanupatkul(Chulalongkorn University), Yumei Cao(Baylor College of Medicine), Steven M. Asch(RAND Corporation), Jennifer R. Kramer(Michael E. DeBakey VA Medical Center)
Cited by 929
Related Papers
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
|Gastroenterology|2018|796
Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference
|Journal of General Internal Medicine|2009|783
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
|Gastroenterology|2021|577
Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry
|The Journal of Pediatrics|2005|571